Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cincinnati Financial Corporation (CINF) vs GeneDx Holdings Corp (WGS) Price & Performance

Cincinnati Financial CorporationTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Cincinnati Financial Corporation vs GeneDx Holdings Corp — how do they compare? Cincinnati Financial Corporation trades at $182.62 (market cap $27.85B), while GeneDx Holdings Corp trades at $62.44 (market cap $1.85B). The key difference: Cincinnati Financial Corporation is far larger — about 15.1× GeneDx Holdings Corp's market cap, and Cincinnati Financial Corporation pays a 2.09% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

CINFWGS
Market Cap
$27.85B$1.85B
Sector
FinancialsTechnology
52-Week High
$192.03$167.51
52-Week Low
$145.80$34.51
Enterprise Value
$27.52B$1.85B
Dividend Yield
2.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cincinnati Financial Corporation

Cincinnati Financial (CINF) trades at $182.67, up 1.89% with strong technical momentum near recent highs. The stock shows solid fundamentals with a P/E of 10.44, ROE of 18.73%, and consistent earnings beats in recent quarters. Recent news highlights the company's 65-year dividend streak and upcoming Q2 2026 earnings release on July 27, 2026. Operating cash flow improved to $3.11B in 2025, supporting financial stability.

CINF presents a balanced investment case with attractive valuation metrics and strong profitability, though catastrophe losses and claims costs remain key risks. Analyst consensus suggests moderate upside to the $188.67 price target. The stock's technical positioning near resistance at $184 requires monitoring of earnings performance for continued momentum.

GeneDx Holdings Corp

GeneDx Holdings (WGS) trades at $63.85, down 2.73% amid multiple securities class action lawsuits alleging misleading acquisition performance disclosures. The stock shows bearish technical signals with support at $60 and resistance at $65. Fundamentally, the company reported negative net income of -$21.02M for 2025 despite revenue growth to $427.54M, with profitability metrics deteriorating significantly in 2026 projections.

Despite 91% analyst buy ratings and a $75.40 consensus target, substantial legal risks and negative earnings momentum create significant headwinds. The stock faces near-term pressure from litigation while long-term viability depends on reversing negative margin trends and resolving acquisition-related impairment issues that triggered the 49% stock decline cited in lawsuits.

Returns comparison

Trailing returns across standard periods

About Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Read more on CINF

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS